About Us
97国际生物集团
wolwo GROUP
2002年
year established
建设时间
2012年
Rate First
市场占有率第一
2014年
Company Listing
公司上市
作为亚洲最大的脱敏药物研发、生产企业,97国际将继续承继“治病救人、实业报国”的企业宗旨,以高度的社会责任感和完整的质量羁系系统,生产“改善人类的生涯质量、延伸人类的康健寿命”的医药产品,为建设成为“国际医药行业的标记企业”而全力以赴,并同时使公司的股东和员工获得长足的生长和收益。
Caring for human health and improving the life quality
We are committed to changing the backward status of China's pharmaceutical industry. As a member of China's pharmaceutical companies, we hope to make our due contributions to the health and wellbeing of people worldwide.
The core product of Wolwo - "Dermatophagoides Farinae Drops" has helped tens of thousands of patients heal or allergic symptoms alleviated, relieve pain and greatly improve patients’ quality of life.
Wolwo is actively carrying out stem cell research, aiming to develop and apply advanced stem cell technology to treat aging-related degenerative diseases and immune disorders-related diseases.
Pharmaceutical industry is a very special, so is medicine a very special kind of commodity as a tool to maintain life. As a pharmaceutical company, Wolwo is engaged in a business of accumulating good deeds. Treating diseases and saving people is our ultimate mission.